<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="25523">Nicotinamide adenine dinucleotide phosphate</z:chebi> (<z:chebi fb="1" ids="16474">NADPH</z:chebi>) oxidase (NOX) is well known as a major source for <z:chebi fb="1" ids="18421">superoxide</z:chebi> radical generation in leukocytes </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="1" ids="18421">Superoxide</z:chebi> radicals play a significant role in <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e>-reperfusion (I/R) injury </plain></SENT>
<SENT sid="2" pm="."><plain>Recent data have also shown expression of NOX in the brain </plain></SENT>
<SENT sid="3" pm="."><plain>However, the manner by which NOX is involved in pathologic processes after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> remains unknown </plain></SENT>
<SENT sid="4" pm="."><plain>Therefore, we subjected mice deficient in the NOX subunit, gp91(phox) (gp91(phox)-/-), those treated with the NOX inhibitor, <z:chebi fb="0" ids="2781">apocynin</z:chebi>, and <z:mp ids='MP_0002169'>wild-type</z:mp> (WT) mice to 75 mins of focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> followed by reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>At 24 h of reperfusion, the gp91(phox)-/- and <z:chebi fb="0" ids="2781">apocynin</z:chebi>-treated mice showed 50% less <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> and 70% less cleaved spectrin compared with WT mice </plain></SENT>
<SENT sid="6" pm="."><plain>The levels of <z:chebi fb="0" ids="32585">4-hydroxy-2-nonenal</z:chebi>, malondialdehyde, and 8-hydroxy-2'-deoxyguanosine increased significantly after I/R, indicating oxidative brain injury </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase inhibition reduced biomarker generation </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, NOX was involved in postischemic <z:mp ids='MP_0001845'>inflammation</z:mp> in the brains, as less intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 upregulation and less neutrophil infiltration were found in the NOX-inhibited mice after I/R </plain></SENT>
<SENT sid="9" pm="."><plain>Moreover, gp91(phox) expression increased after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, and was further aggravated by genetic copper/zinc-<z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD1) ablation, but ameliorated in SOD1-overexpressing mice </plain></SENT>
<SENT sid="10" pm="."><plain>This study suggests that NOX plays a role in <z:mp ids='MP_0003674'>oxidative stress</z:mp> and <z:mp ids='MP_0001845'>inflammation</z:mp>, thus contributing to ischemic brain injury </plain></SENT>
</text></document>